案例报告:心理多发症的挑战
Anirban Raha1, Aparna Mordekar1
1Older Peoples Liaison Psychiatry Team, The Longley Centre, Norwood Grange Drive, Sheffield, S5 7JT, Sheffield Health Partnership University NHS Foundation Trust, UK.
Oxford medical case reports
|December 29, 2025
概括
这份病例报告详细介绍了一名患有偏执性精神分裂症的患者,该患者患有精神病性多滴水症和低血症. 纳尔特雷被试用,成功地减少了社区中的强迫性饮酒行为.
科学领域:
- 精神病学是一个精神病学.
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心理多发症是偏执性精神分裂症患者的罕见并发症.
- 心理多样性的有效治疗策略仍然有限.
- 管理通常涉及流体限制和行为疗法.
研究的目的:
- 报告一个患有偏执性精神分裂症的患者的精神病性多样化病例.
- 探索新的治疗选择,以管理与这种疾病相关的强迫性饮酒行为.
主要方法:
- 进行了对患者病史的全面审查.
- 为了编制案例报告,获得了多学科的咨询.
- 开始对纳尔特雷 (25毫克) 进行试验,以解决强迫性饮酒问题.
主要成果:
- 这名患者出现了慢性低血症,这是心理多症的并发症.
- 药物调整包括停止使用duloxetine和减少 olanzapine剂量.
- 纳尔特雷克松试验表明,患者的饮酒行为有所减少.
结论:
- 纳尔特雷克松在减少强迫性饮酒行为方面表现有前途.
- 这一案例突出了纳尔特雷克松在治疗精神分裂症中的心理多症方面的潜在治疗作用.
相关概念视频
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...


